Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma	Not yet recruiting	Phase 2	2026-08-04		NCT07743632

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Kansas Medical Center	169

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials